Concurrency

CANADA CARBON ANNOUNCES PRIVATE PLACEMENT OF FLOW-THROUGH UNITS AND ORDINARY UNITS

Retrieved on: 
Tuesday, December 5, 2023

Toronto, ON, Canada, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Canada Carbon Inc. (the "Company") (TSX-V : CCB) is pleased to announce a non-brokered private placement of up to 16,666,666 flow-through units (each, a “FT Unit”) at a price of $0.03 per FT Unit for agg­regate gross proceeds of up to $500,000 (the “FT Offering”). Each FT Unit shall be comprised of one (1) flow-through share in the capital of the Company (each, a “FT Share”) and one-half of one (1/2) common share purchase warrant (each, a “Warrant”). Each whole Warrant shall entitle the holder thereof to acquire one common share (each, a “Common Share”) at a price of $0.05 per share for a period of 24 months from the date of issuance. The FT Shares will qualify as “flow-through shares” within the meaning of the Income Tax Act (Canada).

Key Points: 
  • Toronto, ON, Canada, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Canada Carbon Inc. (the "Company") (TSX-V : CCB) is pleased to announce a non-brokered private placement of up to 16,666,666 flow-through units (each, a “FT Unit”) at a price of $0.03 per FT Unit for agg­regate gross proceeds of up to $500,000 (the “FT Offering”).
  • The FT Shares will qualify as “flow-through shares” within the meaning of the Income Tax Act (Canada).
  • In addition to the FT Offering, the Company will be completing a non-brokered private placement of up to 3,333,333 units (each, an “Ordinary Unit”) at a price of $0.03 per Ordinary Unit for aggregate gross proceeds of up to $100,000 (the “Concurrent Offering” and together with the FT Offering, the “Offerings”).
  • Each Ordinary Unit is comprised of one (1) Common Share and one (1) Warrant.

Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)

Retrieved on: 
Tuesday, November 28, 2023

FOSTER CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced a poster presentation of clinical results for vebreltinib in the treatment of NSCLC with MET exon 14 skipping mutation with or without concurrent MET amplification at the 2023 IASLC North America Conference on Lung Cancer (NACLC), being held on December 1 through 3, 2023 in Chicago, Illinois.

Key Points: 
  • FOSTER CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced a poster presentation of clinical results for vebreltinib in the treatment of NSCLC with MET exon 14 skipping mutation with or without concurrent MET amplification at the 2023 IASLC North America Conference on Lung Cancer (NACLC), being held on December 1 through 3, 2023 in Chicago, Illinois.
  • Vebreltinib Efficacy In METex14 Mutant NSCLC With or Without Concurrent MET Amplification, MET GCN Status Distributions Compared With Public Databases

Adventus and Luminex Announce Merger to Create a Growth-Focused Copper-Gold Company in Ecuador

Retrieved on: 
Tuesday, November 21, 2023

TORONTO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Adventus Mining Corporation (“Adventus”) (TSXV: ADZN) (OTCQX: ADVZF) and Luminex Resources Corp. (“Luminex”) (TSXV: LR) (OTCQX: LUMIF) are pleased to announce that they have entered into an arrangement agreement (the “Arrangement Agreement”), pursuant to which Adventus will acquire all of the issued and outstanding common shares of Luminex (the “Luminex Shares”), in exchange for common shares of Adventus (the “Adventus Shares”), by way of a plan of arrangement (the “Transaction”, with the resulting entity referred to as the “Resulting Issuer”). The Transaction will create a combined company that intends to lead the advancement of the El Domo-Curipamba copper-gold project (the “El Domo Project”) towards production and consolidates a large and prospective gold-copper development and exploration portfolio in Ecuador totalling over 135,000 hectares which includes the preliminary economic assessment (“PEA”) stage Condor gold project (the “Condor Project”). Further details of the Transaction are outlined below.

Key Points: 
  • Christian Kargl-Simard, President and CEO of Adventus, commented: “This Transaction is an exciting opportunity to unite complementary assets, teams, and investors to create value for all Adventus and Luminex shareholders.
  • DLA Piper (Canada) LLP, DLA Piper LLP (US) and AVL Abogados are acting as legal counsel to Adventus in Canada, the U.S. and Ecuador, respectively.
  • Borden Ladner Gervais LLP, Troutman Pepper Hamilton Sanders LLP, and Tobar ZVS are acting as legal counsel to Luminex in Canada, the U.S. and Ecuador, respectively.
  • Adventus and Luminex will host a joint conference call on Tuesday, November 22, 2023, at 12:00 pm (noon) ET to discuss the Transaction.

Permian Resources Corporation Announces Pricing of Secondary Public Offering of Class A Common Stock

Retrieved on: 
Tuesday, December 19, 2023

Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the pricing of an underwritten public offering of an aggregate 39,414,415 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), by certain affiliates of NGP Energy Capital Management L.L.C., Riverstone Investment Group LLC and EnCap Investments L.P. (the “Selling Stockholders”), resulting in total gross proceeds of approximately $512.4 million.

Key Points: 
  • Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the pricing of an underwritten public offering of an aggregate 39,414,415 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), by certain affiliates of NGP Energy Capital Management L.L.C., Riverstone Investment Group LLC and EnCap Investments L.P. (the “Selling Stockholders”), resulting in total gross proceeds of approximately $512.4 million.
  • Permian Resources will not sell any shares of Class A common stock in the offering and will not receive any proceeds therefrom.
  • The offering of Class A common stock is not conditioned upon the completion of the Concurrent OpCo Unit Purchase, but the Concurrent OpCo Unit Purchase is conditioned upon the completion of the offering.
  • J.P. Morgan Securities LLC is serving as the underwriter for the offering.

Permian Resources Corporation Announces Secondary Public Offering of Class A Common Stock

Retrieved on: 
Tuesday, December 19, 2023

Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the commencement of an underwritten public offering of an aggregate 39,414,415 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), by certain affiliates of NGP Energy Capital Management L.L.C., Riverstone Investment Group LLC and EnCap Investments L.P. (the “Selling Stockholders”).

Key Points: 
  • Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) today announced the commencement of an underwritten public offering of an aggregate 39,414,415 shares of its Class A Common Stock, par value $0.0001 per share (“Class A common stock”), by certain affiliates of NGP Energy Capital Management L.L.C., Riverstone Investment Group LLC and EnCap Investments L.P. (the “Selling Stockholders”).
  • Permian Resources will not sell any shares of Class A common stock in the offering and will not receive any proceeds therefrom.
  • The offering of Class A common stock is not conditioned upon the completion of the Concurrent OpCo Unit Purchase, but the Concurrent OpCo Unit Purchase is conditioned upon the completion of the offering.
  • The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Nighthawk Gold Closes C$13.0 Million Bought Deal Equity Financing

Retrieved on: 
Tuesday, December 19, 2023

Nighthawk Gold Corp. (“Nighthawk” or the “Company”) (TSX: NHK) is pleased to announce that it has closed the previously announced “bought deal” subscription receipt concurrent private placement (the “Concurrent Financing”) that was being conducted in connection with the arrangement between Nighthawk and Moneta Gold Inc. (“Moneta”) (together with Nighthawk, “MergeCo”) announced on November 28, 2023 (the “Transaction”).

Key Points: 
  • Nighthawk Gold Corp. (“Nighthawk” or the “Company”) (TSX: NHK) is pleased to announce that it has closed the previously announced “bought deal” subscription receipt concurrent private placement (the “Concurrent Financing”) that was being conducted in connection with the arrangement between Nighthawk and Moneta Gold Inc. (“Moneta”) (together with Nighthawk, “MergeCo”) announced on November 28, 2023 (the “Transaction”).
  • Pursuant to the Concurrent Financing, Nighthawk issued 38,235,294 subscription receipts of Nighthawk (the “Subscription Receipts”) at a price of C$0.34 per Subscription Receipt for aggregate gross proceeds of C$13.0 million, which reflects a partial exercise of the Underwriters’ Option.
  • Upon completion of the Transaction, the net proceeds of the Concurrent Financing are expected to be used by MergeCo to fund the exploration and advancement of the Tower Gold Project and Colomac Gold Project and for working capital and general corporate purposes.
  • By virtue of their participation, the Concurrent Financing constitutes a "related party transaction" under applicable securities laws.

Gurobi 11.0 Delivers Global Nonlinear Solving, Speed Enhancements, Dynamic Distributed Tuning, and Enterprise Features

Retrieved on: 
Monday, December 4, 2023

In addition to speed enhancements, Gurobi 11.0 includes a full suite of new features, many of which are based specifically on user requests.

Key Points: 
  • In addition to speed enhancements, Gurobi 11.0 includes a full suite of new features, many of which are based specifically on user requests.
  • Mixed-Integer Nonlinear Programming (MINLP) Problems: Quickly identify precise, globally optimal solutions to complex nonlinear problems.
  • Dynamic Distributed Tuning: With this key enhancement to Gurobi’s popular tuning tool, teams can now share resources across multiple users and jobs when tuning.
  • “Our new global nonlinear solving capabilities will make a big impact for customers,” explained Duke Perrucci, Gurobi’s Chief Executive Officer.

Nighthawk and Moneta Announce At-Market Merger to Create a Leading Canadian Gold Development Company

Retrieved on: 
Tuesday, November 28, 2023

Keyvan Salehi, President, CEO and Director of Nighthawk, and Josef Vejvoda, Interim CEO & Chairman of Moneta, jointly commented: “We believe that the Transaction presents an exciting opportunity to create a leading gold development company by bringing together two cornerstone assets in Canada.

Key Points: 
  • Keyvan Salehi, President, CEO and Director of Nighthawk, and Josef Vejvoda, Interim CEO & Chairman of Moneta, jointly commented: “We believe that the Transaction presents an exciting opportunity to create a leading gold development company by bringing together two cornerstone assets in Canada.
  • MergeCo will be underpinned by a considerable mineral resource of 7.8 million gold ounces in the Indicated category and 10.0 million gold ounces in the Inferred category1.
  • Potential to utilize excess mill capacity in proximity to the Tower Gold Project and accelerate towards near-term cash flow.
  • Synergies – Potential to unlock both G&A and operational efficiencies with seasonal workflow sequencing, staggered and phased development of the Projects.

Barsele and Gold Line Announce Merger to Create Scandinavian Focused District-Scale Gold Exploration & Development Company

Retrieved on: 
Wednesday, December 13, 2023

Consolidating a Prolific Gold District – The Transaction brings together the advanced stage Barsele Project with a district-scale exploration portfolio to consolidate a significant license position in the Gold Line Mineral Belt of Sweden.

Key Points: 
  • Consolidating a Prolific Gold District – The Transaction brings together the advanced stage Barsele Project with a district-scale exploration portfolio to consolidate a significant license position in the Gold Line Mineral Belt of Sweden.
  • Taj Singh, President and CEO of Gold Line, commented: "We are very pleased to be combining with Barsele.
  • The Transaction is subject to approval at a special meeting of Gold Line shareholders (the "Gold Line Meeting") and requires an affirmative vote in favour o the Transaction from 66.67% of the votes cast by Gold Line ‎shareholders at the Gold Line Meeting.
  • An aggregate of 7,996,260 Gold Line Shares, representing approximately 17% of the issued and outstanding Gold Line Shares are subject to these voting support agreements.

Powered by Its Industry-Leading Comprehensive Multi-Omic Database, Caris Life Sciences to Showcase Research at the 2023 San Antonio Breast Cancer Symposium

Retrieved on: 
Monday, December 4, 2023

IRVING, Texas, Dec. 4, 2023 /PRNewswire/ -- Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI, today announced that the company and collaborators within the Caris Precision Oncology Alliance™ (POA) will collectively present findings at the San Antonio Breast Cancer Symposium (SABCS) that illustrate the potential impact of molecular profiling on the treatment of breast cancer. The findings demonstrate the power of Caris' comprehensive clinico-genomic database that enables novel insights into cancer that could have profound effects on a patient's diagnosis, prognosis, care plan, and response to treatment. SABCS is being held December 5-9, 2023 (Booth #1433) in San Antonio, Texas.

Key Points: 
  • "The San Antonio Breast Cancer Symposium continues to be the premiere conference for breast cancer research," said George W. Sledge, Jr. , MD, Executive Vice President and Chief Medical Officer of Caris.
  • "As part of our continuing commitment to the breast cancer community, Caris is proud to share important clinical/translational research created with our academic partners on important breast cancer questions."
  • The results of this analysis indicate that male breast cancer has differential molecular and immune features compared to female breast cancer.
  • Caris will present additional data from studies demonstrating the critical role of precision medicine and molecular profiling in the treatment of breast cancer.